^
Association details:
Biomarker:No biomarker
Cancer:Non-Hodgkin’s Lymphoma
Regimen:AspaMetDex
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
01/05/2023
Excerpt:
Extranodal NK/T-Cell Lymphomas...INDUCTION THERAPY….Useful in certain circumstances...AspaMetDex (pegaspargase, methotrexate, and dexamethasone).